Seelos Therapeutics, Inc. Interest Expense Nonoperating
Seelos Therapeutics, Inc. reported Interest Expense Nonoperating of $23.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2024-08-14
- Seelos Therapeutics, Inc. interest expense nonoperating for the quarter ending 2024-06-30 was $23.00K, a 228.57% increase year-over-year.
- Seelos Therapeutics, Inc. interest expense nonoperating for the quarter ending 2023-06-30 was $7.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month |
|---|---|---|
| 2024-06-30 | $23.00K 10-Q · filed 2024-08-14 | $46.00K 10-Q · filed 2024-08-14 |
| 2023-06-30 | $7.00K 10-Q · filed 2024-08-14 | $14.00K 10-Q · filed 2024-08-14 |